Back to Search
Start Over
Validation of Breast Cancer Margins by Tissue Spray Mass Spectrometry
- Source :
- International Journal of Molecular Sciences, International Journal of Molecular Sciences, Vol 21, Iss 4568, p 4568 (2020), Volume 21, Issue 12
- Publication Year :
- 2020
- Publisher :
- MDPI, 2020.
-
Abstract
- Current methods for the intraoperative determination of breast cancer margins commonly suffer from the insufficient accuracy, specificity and/or low speed of analysis, increasing the time and cost of operation as well the risk of cancer recurrence. The purpose of this study is to develop a method for the rapid and accurate determination of breast cancer margins using direct molecular profiling by mass spectrometry (MS). Direct molecular fingerprinting of tiny pieces of breast tissue (approximately 1 &times<br />1 &times<br />1 mm) is performed using a home-built tissue spray ionization source installed on a Maxis Impact quadrupole time-of-flight mass spectrometer (qTOF MS) (Bruker Daltonics, Hamburg, Germany). Statistical analysis of MS data from 50 samples of both normal and cancer tissue (from 25 patients) was performed using orthogonal projections onto latent structures discriminant analysis (OPLS-DA). Additionally, the results of OPLS classification of new 19 pieces of two tissue samples were compared with the results of histological analysis performed on the same tissues samples. The average time of analysis for one sample was about 5 min. Positive and negative ionization modes are used to provide complementary information and to find out the most informative method for a breast tissue classification. The analysis provides information on 11 lipid classes. OPLS-DA models are created for the classification of normal and cancer tissue based on the various datasets: All mass spectrometric peaks over 300 counts<br />peaks with a statistically significant difference of intensity determined by the Mann&ndash<br />Whitney U-test (p &lt<br />0.05)<br />peaks identified as lipids<br />both identified and significantly different peaks. The highest values of Q2 have models built on all MS peaks and on significantly different peaks. While such models are useful for classification itself, they are of less value for building explanatory mechanisms of pathophysiology and providing a pathway analysis. Models based on identified peaks are preferable from this point of view. Results obtained by OPLS-DA classification of the tissue spray MS data of a new sample set (n = 19) revealed 100% sensitivity and specificity when compared to histological analysis, the &ldquo<br />gold&rdquo<br />standard for tissue classification. &ldquo<br />All peaks&rdquo<br />and &ldquo<br />significantly different peaks&rdquo<br />datasets in the positive ion mode were ideal for breast cancer tissue classification. Our results indicate the potential of tissue spray mass spectrometry for rapid, accurate and intraoperative diagnostics of breast cancer tissue as a means to reduce surgical intervention.
- Subjects :
- 0301 basic medicine
Spectrometry, Mass, Electrospray Ionization
molecular profiling
tissue spray
Breast Neoplasms
Mass spectrometry
01 natural sciences
Cancer recurrence
Catalysis
Article
direct mass spectrometry
Inorganic Chemistry
lcsh:Chemistry
03 medical and health sciences
Breast cancer
breast cancer
Lipidomics
medicine
Biomarkers, Tumor
Humans
Physical and Theoretical Chemistry
Molecular Biology
lcsh:QH301-705.5
Spectroscopy
OPLS
business.industry
Chemistry
discriminant model
010401 analytical chemistry
Organic Chemistry
Significant difference
Margins of Excision
General Medicine
medicine.disease
Linear discriminant analysis
Lipids
0104 chemical sciences
Computer Science Applications
030104 developmental biology
lcsh:Biology (General)
lcsh:QD1-999
Female
Molecular Fingerprinting
Nuclear medicine
business
Subjects
Details
- Language :
- English
- ISSN :
- 14220067
- Volume :
- 21
- Issue :
- 12
- Database :
- OpenAIRE
- Journal :
- International Journal of Molecular Sciences
- Accession number :
- edsair.doi.dedup.....d0b551c7aeb24623bf9e09c19bcdf80a